Predicting Risk of Infection Based on Immunoglobulin Nadirs after CD38 Monoclonal Antibody Treatment in Multiple Myeloma

医学 多发性骨髓瘤 内科学 免疫学 相伴的 达拉图穆马 单克隆抗体治疗 单克隆抗体 抗体 胃肠病学 菌血症 单克隆 来那度胺 生物 抗生素 微生物学
作者
M.R. Cherabuddi,Kathren Shango,Swetha Reddi,Pin Li,Vijaya Donthireddy
出处
期刊:Blood [Elsevier BV]
卷期号:140 (Supplement 1): 10090-10091 被引量:1
标识
DOI:10.1182/blood-2022-166828
摘要

Background: Anti-CD38 monoclonal antibodies are used to treat newly diagnosed and relapsed or refractory multiple myeloma. Previous studies have shown an increased risk of infection while on daratumumab due to the immunosuppressive effect on malignant and normal plasma cells. We sought to retrospectively analyze and further understand the correlation of immunoglobin levels and risk of infection during treatment with anti-CD38 monoclonal antibodies in Multiple Myeloma. Methods: Analysis was performed on data from 261 patients who had received anti-CD38 monoclonal antibody therapy as part of treatment for multiple myeloma between November 11, 2016, and May 11, 2022. 51.7% were male and 48.3% were female. 47.1% of the patients identified as Black, 46% as White, and 6.9% as other races. 14.9% of the patients had Stage I, 41.8% had Stage II and 17.2% had Stage III disease, based on the Revised International Staging System (RISS). Baseline renal disease was present in 35.6% of patients. Median number of anti-CD38 Monoclonal antibody infusions was 16. We examined rates of specific infections (determined by ICD-10 codes), including pneumonia, urinary tract infection, bacteremia, and sepsis, as well as emergency room visits, hospitalizations including ICU stays for up to a year after completing treatment. These rates were correlated with immunoglobulin levels, absolute lymphocyte count, and the presence of concomitant treatment with a proteasome inhibitor or immunomodulator. Results: The overall infection rate among patients receiving anti-CD 38 monoclonal antibody treatment was 32.6%. Bacterial infection developed in 22.2%, viral infections in 17.6%, and fungal infections in 3.4% of patients. SARS-CoV-2 infection rate was 13.4%. The median number of infusions was 15 in those without an infection and 20 in those who developed an infection (p<0.001).19.2% of patients who began anti-CD38 monoclonal antibody treatment during the study period have expired, of whom 56.0 % had an infection. Higher rates of infection were noted with lower IgA levels (p=0.007). There was no significant difference in infection rate with lower IgG and IgA levels or lower absolute lymphocyte levels (p=0.054). However, in patients with an infection there was a longer duration of sub-normal IgG days (114 vs 287 days, p=<0.001), IgA (119.5 vs 215, p=0.006), and IgM (161 vs 274.5, p=0.011). 44.4% of patients had an emergency room visit of whom 40.0% were due to infections (p=0.113). 66.9% of patents required hospital admissions of whom 43.2% had an infection) p<0.001). 18.5% of treated patients required ICU stays of whom 63.9% had an infection) p<0.001). Discussion:Conclusions: A longer duration of subnormal Immunoglobulin levels correlated with higher risk of infection in Multiple Myeloma patients treated with anti-CD 38 monoclonal antibodies. Lowest Ig A levels during treatment correlated with a higher rate of infection while lowest IgG levels did not. Patients who developed infectious complications while on treatment with anti-CD 38 monoclonal antibodies had a significantly higher risk of hospitalization, ICU stays, and death. Prophylactic intravenous immunoglobulin can be studied to evaluate mitigation of infection in the highest risk subpopulation identified in this analysis such as those with prolonged subnormal Immunoglobulin levels. Figure 1View largeDownload PPTFigure 1View largeDownload PPT Close modal

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hu发布了新的文献求助10
刚刚
1秒前
FashionBoy的应助被丁真人采纳,获得10
2秒前
宁静的夏天给布二的求助进行了留言
2秒前
mali123发布了新的文献求助10
2秒前
2秒前
夏目发布了新的文献求助10
3秒前
优美的问芙完成签到,获得积分10
3秒前
丘比特的应助被红枣脆脆鲨采纳,获得10
3秒前
4秒前
ding的应助被浮云客采纳,获得10
4秒前
ASL完成签到,获得积分10
4秒前
CipherSage的应助被菜菜彼得采纳,获得10
4秒前
5秒前
brmxj完成签到,获得积分10
5秒前
5秒前
twooo完成签到 ,获得积分10
5秒前
QuanlongWang发布了新的文献求助10
5秒前
北望发布了新的文献求助10
6秒前
pp完成签到,获得积分10
7秒前
爆米花的应助被ccxr采纳,获得30
8秒前
怡然新梅完成签到,获得积分10
8秒前
春日午后完成签到,获得积分10
8秒前
juju发布了新的文献求助10
8秒前
rflin完成签到,获得积分10
9秒前
9秒前
姚y1234_发布了新的文献求助10
10秒前
共享精神的应助被mia采纳,获得10
10秒前
打打的应助被米饭采纳,获得10
11秒前
pp发布了新的文献求助10
12秒前
13秒前
hu完成签到,获得积分10
13秒前
Ava的应助被清秀送终采纳,获得30
13秒前
Vme50完成签到,获得积分10
13秒前
13秒前
寸烛驱夜发布了新的文献求助10
14秒前
忧虑的靖巧完成签到 ,获得积分0
14秒前
QuanlongWang完成签到,获得积分10
14秒前
852的应助被魁梧的人达采纳,获得10
15秒前
Bruce_Wayne发布了新的文献求助10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183792
求助须知:如何正确求助?哪些是违规求助? 9573020
关于积分的说明 21828776
捐赠科研通 7780959
什么是DOI,文献DOI怎么找? 3434116
关于科研通互助平台的介绍 2558301
邀请新用户注册赠送积分活动 2480611